RxSight, Inc. (RXST) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Rxsight, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.294 Hello, everyone. Thank you for standing by. 00:00:02.294 -- 00:00:05.839 My name is Will, and I will be your operator for today. 00:00:05.839 -- 00:00:10.266 At this time, I would like to welcome each and every one of you to the RxSight 3rd Quarter 00:00:10.266 -- 00:00:15.273 2025 Earnings Conference Call. All lines have been placed on mute to 00:00:15.273 -- 00:00:19.879 prevent any background noise. After the speaker's remarks, there will be a question and 00:00:19.879 -- 00:00:25.007 answer session. If you would like to ask a question during that time, simply press star 00:00:25.007 -- 00:00:28.145 followed by the number one on a telephone keypad. 00:00:28.145 -- 00:00:32.207 I will now turn the call over to Mr. Oliver Moravcevic, 00:00:32.269 -- 00:00:37.053 Vice President of Investor Relations. Please go ahead. 00:00:37.053 -- 00:00:41.978 Thank you, Operator. Presenting today are RxSight President and Chief Executive Officer 00:00:41.978 -- 00:00:46.162 Dr. Ron Kurtz and Chief Financial Officer Shally Toonan. 00:00:46.162 -- 00:00:50.926 Earlier today, RxSight released its financial results for the three months ending September 00:00:50.926 -- 00:00:52.848 30, 2025, 00:00:52.848 -- 00:00:58.084 and updated its full-year guidance. A copy of the press release is available on the company's 00:00:58.084 -- 00:00:59.566 website. 00:00:59.566 -- 00:01:03.610 Before we begin, I would like to inform you that comments and responses to questions 00:01:03.610 -- 00:01:09.637 during today's call reflect management's views as of today, November 5, 2025, 00:01:09.637 -- 00:01:14.882 and will include forward-looking and opinion statements, including predictions, estimates, 00:01:14.882 -- 00:01:18.226 plans, expectations, and other informa...